While CRN is saddened to hear that Steven Tave is leaving his position as director of the Office of Dietary Supplement Programs (ODSP), we congratulate Mr. Tave on his new position in the Office of Regulatory Affairs at FDA.
CRN Applauds Recent House Resolution Recognizing Vitamin D for Decreasing the Severity of COVID-19 — Resolution aims to call attention to benefits of vitamin D in preventing complications from the coronavirus
The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, applauds U.S. Representative Glenn Grothman (R-WI) for introducing a House Resolution (H. Res. 116) that recognizes the potential role vitamin D may play in decreasing the severity of COVID-19.
CRN Dismisses New JAMA Study on Effects of Vitamin C and Zinc on COVID-19 — Study plagued by weak trial design provides little insights into understanding the appropriate role of these nutrients
FEBRUARY 17, 2021
In response to the introduction of the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, introduced by Representatives Kurt Schrader (D-OR) and Morgan Griffith (R-VA), The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, issued the following statement
CRN is pleased with the recent ruling from the Ninth Circuit Court of Appeals regarding the dietary supplement, biotin. The Court upheld a previous decision of the U.S. District Court for the Northern District of California that found federal law expressly preempts the claims of the plaintiff.
The Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement and functional food industry, is pleased to announce that Barry Ritz, Ph.D., Chief Scientific Officer and Vice President, Professional R&D and Regulatory Affairs, Atrium Innovations, has been elevated to chair of the association’s Board of Directors. Dr. Ritz was elected Chair-Elect in 2019 and will hold the chairman position through 2022, succeeding David Campbell, Vice President, Regulatory Affairs NA and Global Regulatory Affairs, Bayer Consumer Healthcare. Mr. Campbell will continue to serve on the Board as immediate past chair.
—Failure to act results in continued growth of unregulated CBD marketplace and places consumers at risk of dangerous products—
The new initiative explains complex dietary supplement industry topics and is intended to help non-industry audiences. The series is hosted by expert CRN staffers.
DECEMBER 29, 2020
CRN Applauds FTC Announcement Against Illegal CBD Products—Reminder to all of need for legal pathway to market for CBD in dietary supplements
Washington, D.C., December 17, 2020 – In response to an announcement issued today by the Federal Trade Commission (FTC) regarding deceptive mar